Meet Kevin.

I believe in the power of self-advocacy.

Kevin Fowler worked in the pharmaceutical industry for over 25 years in both the commercial and R&D organizations. His career has encompassed a breadth and depth of skills and experiences. During his pharma career, he demonstrated leadership in sales management, training, public affairs, global marketing, patient advocacy, and patient marketing. He formed his own patient advocacy and patient engagement consulting business in 2014, “The Voice of the Patient, Inc. His clients currently include Alexion, Bayer, Dimerix, eGenesis, Memo Therapeutics,Travere Therapeutics, Phreesia, and ProKidney. In 2017, Kevin was selected to be a Patient Editor, Clinical Journal of the American Society of Nephrology. In 2023, he was asked to serve a second term as Patient Voice Editor.

In 2021, Kevin was awarded the American Society of Transplantation Transplant Advocacy Award. He has contributed or been primary author in over 25 articles published in the American Journal of Kidney Disease, American Journal of Transplantation, Clinical Journal of American Society of Nephrology, and Kidney Medicine.

Based upon his personal experiences of having a pre-emptive kidney transplant in 2004, he has a deep passion for patient advocacy and patient engagement. Kevin brings the patient voice to several organizations as a volunteer:

• Board of Directors, Kidney Health Initiative



• Kidney Research Institute, Patient Advisory Committee 


• National Kidney Foundation, Coalition for Kidney Health

• Board of Directors, Improving Renal Outcomes in Children (IROC)

• Global Renal Exercise Network